|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US5554630A
(en)
|
1993-03-24 |
1996-09-10 |
Neurosearch A/S |
Benzimidazole compounds
|
|
AU2682695A
(en)
|
1994-06-20 |
1996-01-15 |
Takeda Chemical Industries Ltd. |
Condensed imidazole compounds, their production and use
|
|
JPH11505524A
(ja)
|
1995-05-01 |
1999-05-21 |
藤沢薬品工業株式会社 |
イミダゾ１，２−ａピリジンおよびイミダゾ１，２−ａピリデジン誘導体、および骨吸収阻害剤としてのその用途
|
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
|
AU6966696A
(en)
|
1995-10-05 |
1997-04-28 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
HU229024B1
(en)
|
1996-07-24 |
2013-07-29 |
Bristol Myers Squibb Pharma Co |
Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
|
|
CA2744096C
(en)
|
1996-07-31 |
2013-07-30 |
Laboratory Corporation Of America Holdings |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
AU734009B2
(en)
|
1997-05-30 |
2001-05-31 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
|
US5990146A
(en)
*
|
1997-08-20 |
1999-11-23 |
Warner-Lambert Company |
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
|
|
US6465484B1
(en)
*
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
EP1049699B1
(en)
|
1998-01-28 |
2004-04-21 |
Bristol-Myers Squibb Pharma Company |
Pyrazolotriazines as crf antagonists
|
|
CA2341409A1
(en)
|
1998-08-31 |
2000-03-09 |
Merck And Co., Inc. |
Novel angiogenesis inhibitors
|
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6316444B1
(en)
|
1999-06-30 |
2001-11-13 |
Merck & Co., Inc. |
SRC kinase inhibitor compounds
|
|
WO2001000207A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
DE60006541D1
(de)
*
|
1999-06-30 |
2003-12-18 |
Merck & Co Inc |
Src-kinase hemmende verbindungen
|
|
JP2001057292A
(ja)
|
1999-08-20 |
2001-02-27 |
Toray Ind Inc |
発光素子
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
GB9921150D0
(en)
|
1999-09-07 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2001021634A1
(en)
|
1999-09-21 |
2001-03-29 |
Lion Bioscience Ag |
Benzimidazole derivatives and combinatorial libraries thereof
|
|
GB9927687D0
(en)
|
1999-11-23 |
2000-01-19 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2003525291A
(ja)
|
2000-03-01 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
２，４−二置換チアゾリル誘導体
|
|
JP2004500389A
(ja)
|
2000-03-09 |
2004-01-08 |
アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
Ｐｐａｒメディエーターの治療での使用
|
|
US20020041880A1
(en)
*
|
2000-07-05 |
2002-04-11 |
Defeo-Jones Deborah |
Method of treating cancer
|
|
ES2311532T3
(es)
|
2000-08-04 |
2009-02-16 |
Warner-Lambert Company Llc |
2-(4-pirdil)amino-6-dialcoxifenil-pirido(2.3-d)pirimidin-7-onas.
|
|
WO2002034748A1
(fr)
|
2000-10-24 |
2002-05-02 |
Sankyo Company, Limited |
Derives d'imidazopyridine
|
|
GB0027561D0
(en)
|
2000-11-10 |
2000-12-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
AU2002221239A1
(en)
|
2000-12-07 |
2002-06-18 |
Astrazeneca Ab |
Therapeutic benzimidazole compounds
|
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
ES2316546T3
(es)
|
2001-02-20 |
2009-04-16 |
Astrazeneca Ab |
2-arilamino-pirimidinas para el tratamiento de trastornos asociados a gsk3.
|
|
SE0100567D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
TWI248936B
(en)
|
2001-03-21 |
2006-02-11 |
Merck Sharp & Dohme |
Imidazo-pyrimidine derivatives as ligands for GABA receptors
|
|
DE10117183A1
(de)
|
2001-04-05 |
2002-10-10 |
Gruenenthal Gmbh |
Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
|
|
DE60227794D1
(de)
*
|
2001-04-26 |
2008-09-04 |
Eisai R&D Man Co Ltd |
Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon
|
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
GB0128499D0
(en)
|
2001-11-28 |
2002-01-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6900208B2
(en)
|
2002-03-28 |
2005-05-31 |
Bristol Myers Squibb Company |
Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
|
|
US7662826B2
(en)
*
|
2002-04-23 |
2010-02-16 |
Shionogi & Co., Ltd. |
Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
DE60318198T2
(de)
|
2002-05-02 |
2008-12-04 |
Merck & Co., Inc. |
Tyrosinkinase-hemmer
|
|
AUPS251402A0
(en)
*
|
2002-05-23 |
2002-06-13 |
Cytopia Pty Ltd |
Kinase inhibitors
|
|
WO2003099811A1
(en)
|
2002-05-23 |
2003-12-04 |
Cytopia Pty Ltd |
Kinase inhibitors
|
|
GB0212049D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0212048D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
AU2003240488A1
(en)
|
2002-06-04 |
2003-12-19 |
Neogenesis Pharmaceuticals, Inc. |
Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents
|
|
PA8577501A1
(es)
*
|
2002-07-25 |
2004-02-07 |
Warner Lambert Co |
Inhibidores de quinasas
|
|
ATE378336T1
(de)
|
2002-09-19 |
2007-11-15 |
Schering Corp |
Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
|
|
GB0223349D0
(en)
*
|
2002-10-08 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2004035579A1
(ja)
|
2002-10-15 |
2004-04-29 |
Takeda Pharmaceutical Company Limited |
イミダゾピリジン誘導体、その製造法および用途
|
|
WO2004052286A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2004052315A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US7826979B2
(en)
*
|
2003-02-14 |
2010-11-02 |
Vertex Pharmaceuticals Incorporated |
Method of modeling complex formation between a query ligan and a target molecule
|
|
US7476670B2
(en)
*
|
2003-02-18 |
2009-01-13 |
Aventis Pharma S.A. |
Purine derivatives, method for preparing, pharmaceutical compositions and novel use
|
|
US7157460B2
(en)
*
|
2003-02-20 |
2007-01-02 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
|
ES2423800T3
(es)
|
2003-03-28 |
2013-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos orgánicos para la inmunopotenciación
|
|
AU2004268950A1
(en)
|
2003-08-21 |
2005-03-10 |
Osi Pharmaceuticals, Inc. |
N3-substituted imidazopyridine-derivatives as c-kit inhibitors
|
|
MXPA06002018A
(es)
*
|
2003-08-21 |
2006-05-31 |
Osi Pharm Inc |
Bencimidazolilo n-sustituidos inhibidores de c-kit.
|
|
US7442709B2
(en)
*
|
2003-08-21 |
2008-10-28 |
Osi Pharmaceuticals, Inc. |
N3-substituted imidazopyridine c-Kit inhibitors
|
|
CA2545425C
(en)
|
2003-12-03 |
2013-09-24 |
Cytopia Research Pty Ltd |
Azole-based kinase inhibitors
|
|
JP2007519720A
(ja)
|
2004-01-28 |
2007-07-19 |
スミスクライン ビーチャム コーポレーション |
チアゾール化合物
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
EP1748048A4
(en)
|
2004-05-10 |
2010-05-26 |
Banyu Pharma Co Ltd |
imidazopyridine
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
AU2005278292B2
(en)
*
|
2004-08-31 |
2011-09-08 |
Msd K.K. |
Novel substituted imidazole derivatives
|
|
MX2007003342A
(es)
|
2004-09-21 |
2007-06-05 |
Synta Pharmaceutical Corp |
Compuestos para inflamacion y usos relacionados con trastornos inmunitarios.
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
KR20070086865A
(ko)
*
|
2004-12-01 |
2007-08-27 |
오에스아이 파마슈티컬스, 인코포레이티드 |
Ｎ-치환된 벤즈이미다졸일 ｃ-ｋｉｔ 억제제 및 조합적인벤즈이미다졸 라이브러리
|
|
CA2594325A1
(en)
|
2004-12-28 |
2006-07-06 |
Takeda Pharmaceutical Company Limited |
Condensed imidazole compound and use thereof
|
|
JP2008526723A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
|
|
DOP2006000051A
(es)
|
2005-02-24 |
2006-08-31 |
Lilly Co Eli |
Inhibidores de vegf-r2 y métodos
|
|
AU2006218403A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
|
KR20080013886A
(ko)
|
2005-04-05 |
2008-02-13 |
파마코페이아, 인코포레이티드 |
면역억제용 퓨린 및 이미다조피리딘 유도체
|
|
FR2884821B1
(fr)
*
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
|
BRPI0616722A2
(pt)
|
2005-09-30 |
2012-12-25 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitÁvel ou um Éster hidrolisÁvel in vivo do mesmo, processo para preparar o mesmo, composiÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel ou um Éster hidrolisÁvel in vivo do mesmo, e, mÉtodos para produzir um efeito anti-proliferaÇço celular e um efeito inibidor cdk2, para tratar cÂncer, e para tratar doenÇas
|
|
EP2001476A4
(en)
|
2006-03-20 |
2010-12-22 |
Synta Pharmaceuticals Corp |
BENZOIMIDAZOLYL-PARAZINE-BASED COMPOUNDS FOR INFLAMMATION USES AND IMMUNE DISORDERS
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
ITVA20060041A1
(it)
|
2006-07-05 |
2008-01-06 |
Dialectica Srl |
Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington
|
|
TW200811134A
(en)
|
2006-07-12 |
2008-03-01 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
EP1882475A1
(en)
|
2006-07-26 |
2008-01-30 |
Novartis AG |
Method of treating disorders mediated by the fibroblast growth factor receptor
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
MX2009006704A
(es)
*
|
2006-12-22 |
2009-06-30 |
Astex Therapeutics Ltd |
Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
|
|
US8131527B1
(en)
|
2006-12-22 |
2012-03-06 |
Astex Therapeutics Ltd. |
FGFR pharmacophore compounds
|
|
MX2009006706A
(es)
|
2006-12-22 |
2009-07-02 |
Astex Therapeutics Ltd |
Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
|
|
US7977336B2
(en)
|
2006-12-28 |
2011-07-12 |
Banyu Pharmaceutical Co. Ltd |
Aminopyrimidine derivatives as PLK1 inhibitors
|
|
WO2008124323A1
(en)
|
2007-04-03 |
2008-10-16 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
|
JP5539864B2
(ja)
|
2007-06-12 |
2014-07-02 |
アカオゲン，インコーポレーテッド |
抗菌剤
|
|
WO2009002534A1
(en)
|
2007-06-26 |
2008-12-31 |
Gilead Colorado, Inc. |
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|